BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17531623)

  • 21. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraception: a review.
    Kubba AA
    Int J Clin Pract; 1998 Mar; 52(2):102-5. PubMed ID: 9624791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Randomized comparative study of GyneFix IN and TCu 380A intrauterine devices].
    Wu S; Hu J; Wu M
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):345-8. PubMed ID: 10806672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intrauterine device today.
    Rioux JE
    J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IUDs struggle to shake off legacy of past.
    Barron T
    Family Plan World; 1992; 2(1):10-1, 31. PubMed ID: 12317120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance and user satisfaction with the intra-uterine contraceptive device in Family Planning Service: the results of a survey in Fife, Scotland, August 2004.
    Tewari R; Kay VJ
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):28-37. PubMed ID: 16546814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine contraception in the year 2001: can intrauterine device use be revived with new improved contraceptive technology?
    Wildemeersch D; Schacht E; Thiery M; Van Kets H
    Eur J Contracept Reprod Health Care; 2000 Dec; 5(4):295-304. PubMed ID: 11245557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cochrane systematic reviews of IUD trials: lessons learned.
    Grimes DA; Lopez LM; Manion C; Schulz KF
    Contraception; 2007 Jun; 75(6 Suppl):S55-9. PubMed ID: 17531618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful use of levonorgestrel intrauterine system in a HIV positive woman.
    Cooling H
    Br J Fam Plann; 1999 Apr; 25(1):25-6. PubMed ID: 10228247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is gestagen IUD a realistic alternative to female sterilization?].
    Bjerge MR; Helm P
    Ugeskr Laeger; 2005 Jun; 167(25-31):2770-2. PubMed ID: 16014263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
    Wu S; Hu J; Wildemeersch D
    Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IUDs safe and effective at nine years of continuous use.
    Prog Hum Reprod Res; 1992; (22):2-3. PubMed ID: 12286011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper intrauterine device use by nulliparous women: review of side effects.
    Hubacher D
    Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contraceptive devices: intravaginal and intrauterine delivery systems.
    Benagiano G; Gabelnick H; Farris M
    Expert Rev Med Devices; 2008 Sep; 5(5):639-54. PubMed ID: 18803474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.